Q&A About Endometrial Cancer Treatment Options

SGLT2 Inhibitors Linked to Endometrial Cancer Survival

A groundbreaking retrospective cohort study has unveiled compelling evidence that sodium-glucose cotransporter-2 inhibitors (SGLT2i), a class of medications primarily used to manage type 2 diabetes mellitus, may dramatically improve survival outcomes in patients diagnosed with endometrial cancer. Published in the renowned journal BMC Cancer, this research signals a potential paradigm shift in adjunctive cancer therapy by intertwining oncological…

Clinically Speaking: Questions and Answers About Endometrial Cancer Treatment Options

Endometrial cancer is cancer that forms in the lining of the uterus, which is called the endometrium. It is the fourth most common cancer for women in the United States and affects 1 in 50 women.The good news? Doctors have many tools for treating endometrial cancer, and they work well, especially when the cancer is caught early. More than 80% of women diagnosed with endometrial cancer are alive five years later — and this number jumps to 95% if …

Q&A About Endometrial Cancer Treatment Options

Endometrial cancer is cancer that forms in the lining of the uterus, which is called the endometrium. It is the fourth most common cancer for women in the United States and affects 1 in 50 women. The good news? Doctors have many tools for treating endometrial cancer, and they work well, especially when the cancer is caught early. More than 80% of women diagnosed with endometrial cancer are alive five years later — and this number jumps to 95% if…